Form 4: Guardant Health CFO Reports Scheduled RSU Vesting and Tax Withholding

Guardant Health's Chief Financial Officer, Michael Brian Bell, reported the scheduled vesting of Restricted Stock Units and subsequent tax-related share withholding on June 15, 2025, under a Rule 10b5-1 plan.

Summary

• Michael Brian Bell, Chief Financial Officer of Guardant Health, Inc. (GH), filed a Form 4 reporting changes in his beneficial ownership of company securities.
• On June 15, 2025, Mr. Bell acquired 1,233 shares of Common Stock through the vesting of a Restricted Stock Unit (RSU) award granted on May 9, 2022. This award vests over a four-year period, with 25% vesting on March 15, 2023, and the remainder in equal quarterly installments.
• On the same date, Mr. Bell acquired an additional 2,039 shares of Common Stock from the vesting of another RSU award granted on June 9, 2023. This award vests over a three-year period, with 33% vesting on June 15, 2024, and the remainder in equal quarterly installments.
• Concurrently, 1,659 shares of Common Stock were disposed of (withheld by the Company) at a price of $49.29 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Mr. Bell's direct beneficial ownership of Common Stock is 42,001 shares.
• He also beneficially owns 3,699 Restricted Stock Units from the May 9, 2022 grant and 8,156 Restricted Stock Units from the June 9, 2023 grant, which are yet to vest.

Sentiment

Score: 6

Explanation: The filing reports routine, pre-scheduled RSU vesting and tax-related share withholding for a key executive. This is a standard compensation event and indicates continued insider ownership, which is generally neutral to slightly positive as it aligns executive interests with shareholders, but does not signal new strategic developments or significant changes in company outlook.

Positives

• The vesting of Restricted Stock Units indicates continued executive compensation alignment with shareholder interests.
• The transactions are part of a pre-arranged Rule 10b5-1 plan, demonstrating a structured approach to equity management and reducing concerns about opportunistic trading.

Negatives

• A portion of the vested shares was withheld for tax purposes, reducing the net shares received by the executive.

Future Outlook

This Form 4 reports pre-scheduled transactions related to executive compensation and does not provide forward-looking statements or guidance on company performance.

Industry Context

This filing is a routine insider transaction report, common across all publicly traded companies, reflecting standard executive compensation practices involving equity awards. It does not provide specific insights into broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: The vesting and retention of shares by a key executive like the CFO generally indicates continued alignment of management's interests with those of shareholders through equity ownership.

Next Steps

• Future quarterly installments of the remaining Restricted Stock Units are expected to vest according to their respective schedules.

Key Dates

Recommendation

Keywords

Guardant Health, GH, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Michael Brian Bell, Chief Financial Officer, Share Ownership, 10b5-1 Plan